Knowledge mapping of anaplastic thyroid cancer treatments: a bibliometric analysis (2000-2023)

Shiqiang Liu1, Xingmin Yan1, Yalong Yang2

  • 1Department of Thyroid and Breast Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Oncology
|February 29, 2024
PubMed
Abstract

Insights

Anaplastic thyroid cancer (ATC) research is growing, with immunotherapy and targeted therapy emerging as key areas. This bibliometric analysis maps the scientific landscape to guide future treatment strategies.

Area of Science:

  • Oncology
  • Bibliometrics

Background:

  • Anaplastic thyroid cancer (ATC) is a rare but highly aggressive malignancy with a poor prognosis.
  • Limited effective therapeutic options necessitate a deeper understanding of ATC research.
  • Bibliometric analysis provides a comprehensive overview of the scientific literature on ATC treatment.

Purpose of the Study:

  • To conduct a bibliometric network analysis of ATC treatment research.
  • To identify research trends, developmental frameworks, and academic frontiers in ATC treatment.
  • To offer insights for future research funding and strategic development.

Main Methods:

  • Systematic search of the Web of Science Core Collection (WoSCC) database for ATC treatment publications (2000-2023).
  • Utilized VOSviewers, CiteSpace, and the R package 'bibliometrix' for bibliometric analysis.
  • Analyzed publication quantity, influential countries, institutions, journals, authors, and keywords.

Main Results:

  • Analyzed 1223 publications by 6937 scholars across 53 areas and 1402 institutions.
  • The United States and China are leading nations in ATC research.
  • Emerging research hotspots include immunotherapy, targeted therapy, and prognostic factors, with keywords like apoptosis, survival, and metastasis being prevalent.

Conclusions:

  • This bibliometric analysis offers a comprehensive overview of research trends in ATC treatment.
  • Identified key research frontiers and prevalent directions in recent years.
  • Provides vital insights for funding and strategic development in ATC treatment research.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K